hotspot -WSS

hotspot

author：comprehensive 2025-10-01 18:47:09 - browse：16

Have you ever seen a mouse with a set of muscles more appropriate for a bodybuilder or comic book superhero?

Well, 25 years ago, researchers at Johns Hopkins University made it happen. By silencing a gene responsible for producing a protein called myostatin, they directed tiny mouse bodies to grow double the amount of lean muscle they would normally, leading to mice with bulky arms, defined pectorals, and an overall more substantial body mass. They were dubbed “mighty mice.”

Now, biotech startups are hoping to use those findings to create what they believe will be better weight loss medications. In the last several months, multiple companies have disclosed they are testing drugs that preserve or grow muscle while reducing fat, as shown in the updated STAT Obesity Drug Tracker. They hope that their drugs, possibly when used in conjunction with existing obesity treatments, will result in healthier weight loss.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： CDC: Uninsured rate hit 'record low' right as states cut Medicaid

leisure time

WSS

Microsoft strikes partnership with Duke Health to advance health AI

TytoCare raises $49 million to build out AI

Medicare Advantage beneficiaries sue Humana over algorithm use

Can sheer will power keep patients alive in their dying hours?

Hospitals owned by private equity see complications spike 25%

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

explore

hotspot

Wikipedia

ChatGPT in medicine: STAT answers readers' burning questions

Dramatically reducing cancer deaths requires the PASTEUR Act

Malaria cases in Florida and Texas: Here’s what you need to know

How to keep neuroscience’s past racism from being its future

Apple is now the first public company to be valued at $3 trillion

Can sheer will power keep patients alive in their dying hours?

Medical leaders decry Supreme Court decision on affirmative action

SNAP should offer more nutrition education

As demand for Covid shots wanes, Moderna seeks its next success

Medicare drug price negotiation hasn't dried up venture capital

focus

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

My superpower is killing ticks

Prime Medicine, Myeloid Therapeutics clash over genome

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

Violet CEO on training clinicians to promote more inclusive care

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

focus

hotspot

leisure time

focus